- Home
- ARCT vs EU Comparison
ARCT vs EU Comparison
Compare ARCT & EU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARCT
- EU
- Stock Information
- Founded
- ARCT 2013
- EU 2009
- Country
- ARCT United States
- EU United States
- Employees
- ARCT N/A
- EU N/A
- Industry
- ARCT Biotechnology: Pharmaceutical Preparations
- EU Other Metals and Minerals
- Sector
- ARCT Health Care
- EU Basic Materials
- Exchange
- ARCT Nasdaq
- EU Nasdaq
- Market Cap
- ARCT 320.8M
- EU 445.3M
- IPO Year
- ARCT N/A
- EU N/A
- Fundamental
- Price
- ARCT $17.32
- EU $2.23
- Analyst Decision
- ARCT Strong Buy
- EU Strong Buy
- Analyst Count
- ARCT 10
- EU 1
- Target Price
- ARCT $50.88
- EU $4.00
- AVG Volume (30 Days)
- ARCT 536.4K
- EU 4.7M
- Earning Date
- ARCT 11-06-2025
- EU 08-11-2025
- Dividend Yield
- ARCT N/A
- EU N/A
- EPS Growth
- ARCT N/A
- EU N/A
- EPS
- ARCT N/A
- EU N/A
- Revenue
- ARCT $122,122,000.00
- EU $44,524,000.00
- Revenue This Year
- ARCT N/A
- EU $33.35
- Revenue Next Year
- ARCT $31.09
- EU $112.45
- P/E Ratio
- ARCT N/A
- EU N/A
- Revenue Growth
- ARCT N/A
- EU N/A
- 52 Week Low
- ARCT $8.04
- EU $1.01
- 52 Week High
- ARCT $25.88
- EU $4.44
- Technical
- Relative Strength Index (RSI)
- ARCT 54.49
- EU 38.43
- Support Level
- ARCT $17.38
- EU $2.26
- Resistance Level
- ARCT $18.69
- EU $2.37
- Average True Range (ATR)
- ARCT 1.00
- EU 0.11
- MACD
- ARCT -0.11
- EU 0.00
- Stochastic Oscillator
- ARCT 44.23
- EU 3.45
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.
About EU enCore Energy Corp.
enCore Energy Corp together with its subsidiary, is engaged in the acquisition and exploration of resource properties of uranium resource properties in the United States. The holds a portfolio of uranium assets located in New Mexico, South Dakota, Wyoming, Texas, Utah, Colorado, and Arizona in the USA, and is advancing its properties with a focus on utilizing in-situ recovery. The company's Projects are South Texas Operations, Dewey-Burdock Project, Gas Hills Project, Crownpoint & Hosta Butte Project, PFN (Prompt Fission Neutron) Technology, and Other Assets.